Last $30.25 USD
Change Today +0.16 / 0.53%
Volume 26.5M
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Helen H. Hobbs M.D.

Independent Director, Member of Corporate Governance Committee and Member of Science & Technology Committee, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
61$277,905

Background*

Dr. Helen H. Hobbs, M.D., is Investigator for the Howard Hughes Medical Institute. Dr. Hobbs is a Professor of Internal Medicine and Molecular Genetics at the University of Texas (UT) Southwestern Medical Center, where she has been a faculty member for more than 20 years. She serves as a Director of its McDermott Center for Human Growth and Development. Considered a leading geneticist in the arena of cholesterol metabolism and heart attacks, Dr. Hobbs was elected to ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

2011-Present
Independent Director, Member of Corporate Governance Committee and Member of Science & Technology Committee

Education*

BA
The Board of Trustees of The Leland Stanford Junior University
MD
Case Western Reserve University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$140,405
Total Calculated Compensation$277,905
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $30.25 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.